Rabbit Polyclonal XCT antibody. Suitable for Flow Cyt, WB, ICC/IF and reacts with Human, Mouse samples. Cited in 25 publications.
View Alternative Names
Cystine/glutamate transporter, Amino acid transport system xc-, Calcium channel blocker resistance protein CCBR1, Solute carrier family 7 member 11, xCT, SLC7A11
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-xCT antibody (AB216876)
Immunofluorescent analysis of PC-3 (human prostate adenocarcinoma cell line) cells labeling xCT with ab216876 at 10 μg/mL for 1 hour, followed by anti-Rabbit IgG DyLight™ 488 Conjugated Preadsorbed secondary antibody at 5 μg/mL for 1 hour at RT (green). Cells were fixed with 100% methanol.
The nuclear counter stain is DAPI (blue).
A : DAPI
B : Primary followed by Anti-rabbit IgG Dylight™ 488
C : Merged images
D : Secondary only control
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-xCT antibody (AB216876)
Flow cytometric analysis of human breast carcinoma cells labeling xCT with ab216876 at 1 μg/mL for 1 hour at 4°C. Rabbit IgG Antibody Dylight™488 Conjugated pre-adsorbed secondary antibody was used at 1 μg/mL for one hour on ice.
Left panels : Unstained.
Middle panels : Secondary antibody only.
Right panels : Primary and secondary antibodies.
- WB
Supplier Data
Western blot - Anti-xCT antibody (AB216876)
Dilution buffer : 0.01% sodium azide in PBS.
xCT processing caused by dimerization, glycosylation, and/or phosphorylation may cause other bands.
All lanes:
Western blot - Anti-xCT antibody (ab216876) at 1/1000 dilution
Lane 1:
A549 (human lung carcinoma cell line) whole cell lysate at 10 µg
Lane 2:
HCT 116 (human colorectal carcinoma cell line) whole cell lysate at 10 µg
Lane 3:
HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 10 µg
Secondary
All lanes:
anti-rabbit secondary DyLight 488 antibody at 1/20000 dilution
Predicted band size: 55 kDa
Observed band size: 56 kDa
false
- WB
Supplier Data
Western blot - Anti-xCT antibody (AB216876)
Exposure time : 15-30 seconds.
Blocking buffer : 5% BSA.
Dilution buffer : 0.01% sodium azide in PBS.
xCT processing caused by dimerization, glycosylation, and/or phosphorylation may cause other bands.
All lanes:
Western blot - Anti-xCT antibody (ab216876) at 1/1000 dilution
Lane 1:
Recombinant Bcl3 (unrelated negative control) at 10 µg
Lane 2:
NIH/3T3 (mouse embryonic fibroblast cell line) whole cell lysate at 10 µg
Lane 3:
A549 (human lung carcinoma cell line) whole cell lysate at 10 µg
Secondary
All lanes:
anti-rabbit secondary HRP antibody at 1/70000 dilution
Predicted band size: 55 kDa
Observed band size: 56 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (25)
Recent publications for all applications. Explore the full list and refine your search
Hereditas 162:104 PubMed40514721
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in aging neuroscience 17:1551404 PubMed40400910
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 301:108312 PubMed39955059
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 22:744 PubMed39614277
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 28:e70103 PubMed39334527
2024
Applications
Unspecified application
Species
Unspecified reactive species
ACS omega 9:7463-7470 PubMed38405445
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular nutrition & food research 68:e2300734 PubMed38389170
2024
Applications
Unspecified application
Species
Unspecified reactive species
Aging 16:746-761 PubMed38198162
2024
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 9:e20163 PubMed37771529
2023
Applications
Unspecified application
Species
Unspecified reactive species
Current neuropharmacology 22:2045-2058 PubMed37711124
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com